United States · FDA National Drug Code directory
Pioglitazone HCL and Metformin HCL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-281_05c4925c-a14b-4229-81b0-abb0f5f3814c
- Product NDC
- 13668-281
- Form
- TABLET
- Composition / generic term
- Pioglitazone HCL and Metformin HCL
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250901
- Source listing expiry
- 20271231
Source-listed ingredients
- METFORMIN HYDROCHLORIDE — 850 mg/1
- PIOGLITAZONE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (13668-281-05) · 13668-281-05
- 180 TABLET in 1 BOTTLE (13668-281-33) · 13668-281-33
- 750 TABLET in 1 BOTTLE (13668-281-49) · 13668-281-49
- 60 TABLET in 1 BOTTLE (13668-281-60) · 13668-281-60
- 100 TABLET in 1 CARTON (13668-281-74) · 13668-281-74
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →